Healthcare provider profile · identity verified

Daniel A Veno, MD

Family Practice · LEOMINSTER, MA · NPI 1821038738

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	924	258
Amlodipine Besylate	Amlodipine Besylate	388	107
Lisinopril	Lisinopril	353	109
Levothyroxine Sodium	Levothyroxine Sodium	255	62
Omeprazole	Omeprazole	228	61
Tamsulosin Hcl	Tamsulosin Hcl	199	63
Losartan Potassium	Losartan Potassium	185	58
Simvastatin	Simvastatin	184	47
Metoprolol Succinate	Metoprolol Succinate	181	56
Hydrochlorothiazide	Hydrochlorothiazide	177	54
Metformin Hcl	Metformin Hcl	165	36
Rosuvastatin Calcium	Rosuvastatin Calcium	159	48
Trulicity	Dulaglutide	148	24
Atenolol	Atenolol	137	40
Allopurinol	Allopurinol	135	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	119	38
Gabapentin	Gabapentin	114	31
Sertraline Hcl	Sertraline Hcl	113	37
Eliquis	Apixaban	110	30
Metformin Hcl Er	Metformin Hcl	96	31
Trazodone Hcl	Trazodone Hcl	93	28
Furosemide	Furosemide	82	29
Spironolactone	Spironolactone	82	19
Albuterol Sulfate Hfa	Albuterol Sulfate	79	30
Jardiance	Empagliflozin	73	17
Metoprolol Tartrate	Metoprolol Tartrate	70	19
Famotidine	Famotidine	67	15
Finasteride	Finasteride	62	19
Glipizide	Glipizide	60	14
Pantoprazole Sodium	Pantoprazole Sodium	58	16
Fluticasone Propionate	Fluticasone Propionate	57	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	14
Prednisone	Prednisone	53	22
Valsartan	Valsartan	51	20
Chlorhexidine Gluconate	Chlorhexidine Gluconate	50	suppressed
Warfarin Sodium	Warfarin Sodium	49	18
Doxazosin Mesylate	Doxazosin Mesylate	47	suppressed
Mirtazapine	Mirtazapine	42	11
Pravastatin Sodium	Pravastatin Sodium	41	12
Chlorthalidone	Chlorthalidone	37	12
Synthroid	Levothyroxine Sodium	36	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Lorazepam	Lorazepam	31	18
Montelukast Sodium	Montelukast Sodium	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	11
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	11
Xarelto	Rivaroxaban	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Alprazolam	Alprazolam	26	11
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Baclofen	Baclofen	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Torsemide	Torsemide	23	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	15
Ibuprofen	Ibuprofen	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Ozempic	Semaglutide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Cephalexin	Cephalexin	18	15
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Diazepam	Diazepam	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Methenamine Hippurate	Methenamine Hippurate	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Colchicine	Colchicine	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Primidone	Primidone	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Relpax	Eletriptan Hydrobromide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Desipramine Hcl	Desipramine Hcl	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sure Comfort	Syringe And Needle,insulin,1ml	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error